ArticleMolecular pharmaceutics2018

Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.

Federico Baruffaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.